150 related articles for article (PubMed ID: 15105904)
1. P-31 magnetic resonance spectroscopy. A tool for diagnostic purposes and pathophysiological insights in muscle diseases.
Mattei JP; Bendahan D; Cozzone P
Reumatismo; 2004; 56(1):9-14. PubMed ID: 15105904
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of muscle MR spectroscopy.
Taylor DJ
Semin Musculoskelet Radiol; 2000; 4(4):481-502. PubMed ID: 11371330
[TBL] [Abstract][Full Text] [Related]
3. [Non-invasive investigation of muscle function using 31P magnetic resonance spectroscopy and 1H MR imaging].
Bendahan D; Mattei JP; Guis S; Kozak-Ribbens G; Cozzone PJ
Rev Neurol (Paris); 2006 Apr; 162(4):467-84. PubMed ID: 16585908
[TBL] [Abstract][Full Text] [Related]
4. Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.
Argov Z; Löfberg M; Arnold DL
Muscle Nerve; 2000 Sep; 23(9):1316-34. PubMed ID: 10951434
[TBL] [Abstract][Full Text] [Related]
5. [Non invasive investigation of muscle diseases using 31P magnetic resonance spectroscopy: potential in clinical applications].
Bendahan D; Mattéi JP; Kozak-Ribbens G; Cozzone PJ
Rev Neurol (Paris); 2002 May; 158(5 Pt 1):527-40. PubMed ID: 12072821
[TBL] [Abstract][Full Text] [Related]
6. MR spectroscopy and imaging in metabolic myopathies.
Argov Z; Arnold DL
Neurol Clin; 2000 Feb; 18(1):35-52. PubMed ID: 10658168
[TBL] [Abstract][Full Text] [Related]
7. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease.
Matthews PM; Allaire C; Shoubridge EA; Karpati G; Carpenter S; Arnold DL
Neurology; 1991 Jan; 41(1):114-20. PubMed ID: 1985275
[TBL] [Abstract][Full Text] [Related]
8. Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders.
Argov Z; Bank WJ
Ann Neurol; 1991 Jul; 30(1):90-7. PubMed ID: 1834009
[TBL] [Abstract][Full Text] [Related]
9. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis.
Park JH; Olsen NJ; King L; Vital T; Buse R; Kari S; Hernanz-Schulman M; Price RR
Arthritis Rheum; 1995 Jan; 38(1):68-77. PubMed ID: 7818575
[TBL] [Abstract][Full Text] [Related]
10. A prospective study to evaluate the impact of 31P-MRS to determinate mitochondrial dysfunction in skeletal muscle of ALS patients.
Grehl T; Fischer S; Müller K; Malin JP; Zange J
Amyotroph Lateral Scler; 2007 Feb; 8(1):4-8. PubMed ID: 17364428
[TBL] [Abstract][Full Text] [Related]
11. Discriminant factor analysis of 31P NMR spectroscopic data in myopathies.
Morvan D; Jehenson P; Duboc D; Syrota A
Magn Reson Med; 1990 Feb; 13(2):216-27. PubMed ID: 2314212
[TBL] [Abstract][Full Text] [Related]
12. Quantification of skeletal muscle mitochondrial function by 31P magnetic resonance spectroscopy techniques: a quantitative review.
Kemp GJ; Ahmad RE; Nicolay K; Prompers JJ
Acta Physiol (Oxf); 2015 Jan; 213(1):107-44. PubMed ID: 24773619
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of muscle diseases using artificial neural network analysis of 31P MR spectroscopy data.
Kari S; Olsen NJ; Park JH
Magn Reson Med; 1995 Nov; 34(5):664-72. PubMed ID: 8544686
[TBL] [Abstract][Full Text] [Related]
14. Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study.
Argov Z; Bank WJ; Maris J; Peterson P; Chance B
Neurology; 1987 Feb; 37(2):257-62. PubMed ID: 3808305
[TBL] [Abstract][Full Text] [Related]
15. Development and applications of in vivo clinical magnetic resonance spectroscopy.
Cox IJ
Prog Biophys Mol Biol; 1996; 65(1-2):45-81. PubMed ID: 9029941
[TBL] [Abstract][Full Text] [Related]
16. [Metabolic myopathies in adulthood. Features and clues for diagnosis].
Eymard B; Laforêt P
Rev Med Interne; 2001 Dec; 22 Suppl 3():328s-337s. PubMed ID: 11794877
[TBL] [Abstract][Full Text] [Related]
17. [Spectroscopy of phosphorus in nuclear magnetic resonance. General review of clinical applications to the study of human skeletal muscle].
Kaminsky P; Escanyé JM; Klein M; Robin-Lherbier B; Walker P; Robert J; Duc M
Rev Med Interne; 1991; 12(2):128-30, 133-8. PubMed ID: 1852995
[TBL] [Abstract][Full Text] [Related]
18. [Nuclear magnetic resonance and aspects of its use in diagnosis and research on metabolic disorders of skeletal muscles].
Lahucký J; Liptaj T
Cesk Fysiol; 1996 Dec; 45(4):203-10. PubMed ID: 8998831
[TBL] [Abstract][Full Text] [Related]
19. Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia.
Reddy R; Keshavan MS
Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):401-5. PubMed ID: 14623493
[TBL] [Abstract][Full Text] [Related]
20. 31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy.
Jeppesen TD; Quistorff B; Wibrand F; Vissing J
J Neurol; 2007 Jan; 254(1):29-37. PubMed ID: 17278044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
